Q32 Bio Inc. (QTTB)
NASDAQ: QTTB · Real-Time Price · USD
3.320
-0.300 (-8.29%)
At close: Dec 5, 2025, 4:00 PM EST
3.270
-0.050 (-1.51%)
After-hours: Dec 5, 2025, 7:59 PM EST

Q32 Bio Stock Forecast

Stock Price Forecast

The 6 analysts with 12-month price forecasts for Q32 Bio stock have an average target of 12.17, with a low estimate of 3.00 and a high estimate of 22. The average target predicts an increase of 266.57% from the current stock price of 3.32.

Analyst Consensus: Hold
Target Low Average Median High
Price $3.00 $12.17 $15 $22
Change -9.64% +266.57% +351.81% +562.65%
* Price targets were last updated on Mar 12, 2025.

Analyst Ratings

The average analyst rating for Q32 Bio stock from 7 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Rating Jun '25Jul '25Aug '25Sep '25Oct '25Nov '25
Strong Buy 000000
Buy 333332
Hold 555555
Sell 000000
Strong Sell 000000
Total 888887

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Wells Fargo
Wells Fargo
Hold
Maintains
$16$15
Hold Maintains $16$15 +351.81% Mar 12, 2025
BMO Capital
BMO Capital
Hold
Downgrades
$22$3
Hold Downgrades $22$3 -9.64% Feb 11, 2025
Piper Sandler
Piper Sandler
Hold
Downgrades
$20$4
Hold Downgrades $20$4 +20.48% Feb 11, 2025
BMO Capital
BMO Capital
Buy
Maintains
$64$22
Buy Maintains $64$22 +562.65% Dec 12, 2024
Guggenheim
Guggenheim
Hold
Downgrades
n/a
Hold Downgrades n/a n/a Dec 12, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-2.81
from -6.58
EPS Next Year
-5.70
from -2.81
Fiscal Year FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 FY 2027
Period Ending Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026 Dec 31, 2027
Revenue
-6.65M-6.65M----
Revenue Growth
-------
EPS
-5.81-6.09-153.96-6.58-2.81-5.70-4.90
EPS Growth
-------
Forward PE
-------
No. Analysts ----444
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 202520262027
High n/a n/a
Avg n/a n/a
Low n/a n/a

Revenue Growth

Revenue Growth 202520262027
High - -
Avg - -
Low - -

EPS Forecast

EPS 202520262027
High -2.27 -1.19
Avg -2.81 -5.70
Low -3.28 -9.85

EPS Growth

EPS Growth 202520262027
High - -
Avg - -
Low - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.